Governance Genmab A/S

GMAB

DK0010272202

Biotechnology & Medical Research

Real-time Estimate Cboe Europe Other stock markets 15:53:31 15/01/2026 GMT			5-day change	1st Jan Change
2,171.00 ^DKK	-3.55%		+1.02%	+7.15%

07:08am	Jyske Bank Raises Genmab Target Price to 2,300 Danish Kroner (2,000), Reiterates Hold - BN	FW
01-14	Genmab A/S Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 03:45 PM

Executive Committee: Genmab A/S

Manager

Positions heldSince

Jan van de Winkel

65 year

Chief Executive Officer	31/05/2010
Founder	10/06/1998
President	31/05/2010

Rayne Waller

Chief Tech/Sci/R&D Officer

15/08/2024

Christopher Cozic

48 year

Human Resources Officer

31/12/2016

Tahamtan Ahmadi

53 year

Chief Tech/Sci/R&D Officer

31/01/2021

Gregory David Emil Mueller

54 year

General Counsel

30/06/2025

Anthony Pagano

48 year

Director of Finance/CFO

29/02/2020

Andrew Carlsen

Investor Relations Contact

Composition of the Board of Directors: Genmab A/S

Director

CommitteesSince

Deirdre Connelly

65 year

Compensation Committee	25/03/2020
Governance Committee Chair	25/03/2020
Nominating Committee Chair	25/03/2020
Audit Committee	25/03/2020
Executive Committee
Governance Committee	09/08/2016
Compensation Committee Chair	25/05/2016
Finance Committee	25/03/2020

Anders Gersel Pedersen

75 year

Governance Committee	31/10/2003
Nominating Committee	31/10/2003
Compensation Committee Chair	31/12/2019
Audit Committee	31/12/2019
Finance Committee	31/12/2013
Nominating Committee Chair	31/12/2019

Elizabeth O'Farrell

61 year

Audit Committee	28/03/2022
Compensation Committee Chair	31/12/2019
Audit Committee Chair	31/01/2021
Finance Committee	28/03/2022
Compensation Committee	28/03/2022

Rolf K. Hoffmann

65 year

Audit Committee	31/12/2016
Finance Committee	31/12/2016
Compensation Committee	14/06/2023
Nominating Committee	14/06/2023

Pernille Erenbjerg

59 year

Governance Committee	31/12/2014
Nominating Committee	31/12/2014
Audit Committee Chair	26/04/2022
Finance Committee Chair	31/12/2014

Paolo Augusto Paoletti

75 year

Compensation Committee

Mijke Zachariasse

53 year

Director/Board Member

28/03/2019

Martin Schultz

51 year

Director/Board Member

31/12/2021

Latest Appointments: Genmab A/S

12-09	BillionToOne Q3 Swings to Profit, Revenue Rises; Shares Fall After Hours	MT
29/09/25	Top Midday Stories: Electronic Arts Going Private in $55 Billion Deal; Genmab to Acquire Merus for $8 Billion	MT
29/09/25	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Trump, Democrats Meeting	MT
01/07/25	Genmab Announces Changes to Its Executive Committee	CI
01/07/25	Genmab's Chief Legal Officer Steps Down; Successor Named	MT
19/12/24	Aadi Bioscience, Inc. Appoints Baiteng Zhao to its Board of Directors	CI
30/08/24	HOOKIPA Pharma Names Julie O'Neill Nonexecutive Chair	MT

More news

Former Officers and Directors: Genmab A/S

Insider

Positions held

SinceUntil

Birgitte Stephensen

General Counsel

30/06/2025

Anthony Mancini

Chief Operating Officer

22/03/2020

15/08/2024

Takahiro Hamatani

Director/Board Member

31/12/2021

Jonathan Peacock

Director/Board Member	25/03/2020	14/11/2021
Independent Dir/Board Member	25/03/2020	14/11/2021

Suba Krishnan

Corporate Officer/Principal

31/08/2019

31/10/2020

Michael K. Bauer

Chief Tech/Sci/R&D Officer	-	30/09/2020
Corporate Officer/Principal	31/07/2012	-

Mats Gunnar Pettersson

Director/Board Member	16/04/2013	-
Chairman	16/04/2013	25/03/2020
Independent Dir/Board Member	16/04/2013	25/03/2020

David Andrew Eatwell

Director of Finance/CFO

01/06/2008

28/02/2020

Richard Gordon Hibbert

Director/Board Member

31/12/2015

28/03/2019

Rachel Curtis Gravesen

Investor Relations Contact	30/04/2011	10/03/2019
Public Communications Contact	30/04/2011	10/03/2019

Rima Bawarsh Nassar

Director/Board Member

31/12/2018

Burt Malkiel

Director/Board Member	31/03/2010	31/05/2018
Independent Dir/Board Member	31/12/2006	31/05/2018

Paul W. H. I. Parren

Chief Tech/Sci/R&D Officer

31/08/2001

31/07/2017

Steen Lisby

Chief Tech/Sci/R&D Officer

31/12/2007

31/12/2016

Peter Storm Kristensen

Director/Board Member

31/12/2015

Hans Henrik Munch-Jensen

Director/Board Member	25/03/2009	31/12/2014
Independent Dir/Board Member	31/12/2006	31/12/2014

Karsten Havkrog Pedersen

Director/Board Member	28/02/2002	31/03/2013
Independent Dir/Board Member	28/02/2002	31/03/2013

Michael Blair Widmer

Director/Board Member	27/03/2012	31/03/2013
Chairman	28/02/2002	26/04/2012
Independent Dir/Board Member	28/02/2002	31/03/2013

Antonius Theodorus M Wilderbeek

Director/Board Member	05/04/2011	31/03/2013
Independent Dir/Board Member	05/04/2011	31/03/2013

Daniel John Bruno

Comptroller/Controller/Auditor	31/12/2007	31/03/2013
Director/Board Member	24/06/2010	31/03/2013
Comptroller/Controller/Auditor	31/12/2015	-
Director/Board Member	31/12/2015	31/07/2020

Patrick van Berkel

Chief Tech/Sci/R&D Officer

31/12/2002

31/12/2011

Helle Husted

Investor Relations Contact	27/04/2011	30/04/2011
Public Communications Contact	-	27/04/2011

Joris Wilms

Corporate Officer/Principal

30/09/2008

30/11/2010

Eva Ehrnrooth

Chief Tech/Sci/R&D Officer

31/05/2008

31/01/2010

Lisa N. Drakeman

Founder	31/12/1998	31/12/2009
President	31/12/1998	31/12/2009

Ernst H. Schweizer

Director/Board Member

25/03/2009

14/04/2009

Barry Littlejohns

Chief Operating Officer

27/05/2010

Bo Kruse

Comptroller/Controller/Auditor	31/12/1999	31/12/2004
Director of Finance/CFO	31/12/2004	01/06/2008

Claus Juan Møller-San Pedro

Chief Operating Officer

31/12/1998

31/12/2007

Irwin Lerner

Director/Board Member

30/01/2007

Hanne Jensen

Corporate Officer/Principal

31/12/1998

Christina Hahner

Chief Administrative Officer	31/12/2004	-
Public Communications Contact	31/12/2004	-

Annarie Lyles

Corporate Officer/Principal

27/05/2010

Joseph Fred Yospe

Comptroller/Controller/Auditor

31/08/2002

31/08/2004

Nedjad Losic

Director/Board Member	24/06/2010	-
Corporate Officer/Principal	31/12/2003	-

Michael Wolff Jensen

Director of Finance/CFO

31/12/1999

31/12/2002

Jorgen Petersen

Chief Tech/Sci/R&D Officer

31/12/2001

Tom Vink

Director/Board Member	24/06/2010	-
Corporate Officer/Principal	31/12/2001	-

Rikke Glahn Ren

Corporate Officer/Principal

31/12/2000

Ole Baadsgaard

Chief Tech/Sci/R&D Officer	27/05/2010	-
Corporate Officer/Principal	27/05/2010	27/05/2010

Donald Lee Drakeman

Founder

10/06/1998

Florian Schönharting

Founder

10/06/1998

Dorrit T. Andersen

General Counsel

Torben Lund-Hansen

Corporate Officer/Principal

Flemming Heise Pedersen

Director/Board Member

Linda Basse

Chief Tech/Sci/R&D Officer

Jesper Zeuthen

Chairman

Francesco de Rubertis

Director/Board Member

Eva Steiness

Chairman

Age distribution of managers

Parity Men Women

Male	15
Female	4

Of which Executive Committee

Male	7
Female	0

Of which Directors

Male	5
Female	3

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Genmab A/S specializes in the research and development of human and therapeutic antibodies intended for treating cancers, infectious diseases, rheumatoid arthritis, etc. Net sales break down by type of income as follows: - royalties (80.6%); - income from research and development (9.3%); - other (10.1%): primarily income from partnership agreement. At the end of 2024, the group had a portfolio of more than 20 products in clinical development phase and 20 in preclinical development phase. Net sales are distributed geographically as follows: Denmark (91.9%), the United States (4.2%) and Japan (3.9%).

Employees

2,681

Sector

Biotechnology & Medical Research

Calendar

02-05 - Q4 2025 Earnings Release

More about the company